Publikationen in Zusammenarbeit mit Forschern von Hospital Carlos III (101)

2021

  1. Demographic, clinical, and functional determinants of antithrombotic treatment in patients with nonvalvular atrial fibrillation

    BMC Cardiovascular Disorders, Vol. 21, Núm. 1

2020

  1. Imported cysticercosis in Spain: A retrospective case series from the +REDIVI Collaborative Network

    Travel Medicine and Infectious Disease, Vol. 37

  2. Latent and active tuberculosis infections in migrants and travellers: A retrospective analysis from the Spanish +REDIVI collaborative network

    Travel Medicine and Infectious Disease, Vol. 36

2019

  1. A new variant (c.1A>G)in LDLRAP1 causing autosomal recessive hypercholesterolemia: Characterization of the defect and response to PCSK9 inhibition

    Atherosclerosis, Vol. 284, pp. 223-229

  2. Clinicoepidemiological characteristics of viral hepatitis in migrants and travellers of the +Redivi network

    Travel Medicine and Infectious Disease, Vol. 29, pp. 51-57

  3. Functional analysis of new variants at the low-density lipoprotein receptor associated with familial hypercholesterolemia

    Human Mutation, Vol. 40, Núm. 8, pp. 1181-1190

  4. Standards for global cardiovascular risk management arteriosclerosis

    Clinica e Investigacion en Arteriosclerosis, Vol. 31, pp. 1-43

2018

  1. COSMIC project: Consensus on the objectives of the metabolic syndrome in clinic

    Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, Vol. 11, pp. 683-697

  2. Increased indoleamine-2,3-dioxygenase activity is associated with poor clinical outcome in adults hospitalized with influenza in the INSIGHT FLU003Plus study

    Open Forum Infectious Diseases, Vol. 5, Núm. 1

2017

  1. Prediction of long-term outcomes of HIV-infected patients developing non-AIDS events using a multistate approach

    PLoS ONE, Vol. 12, Núm. 9

  2. Prevalence of peripheral artery disease (PAD) and factors associated: An epidemiological analysis from the population-based Screening PRE-diabetes and type 2 DIAbetes (SPREDIA-2) study

    PLoS ONE, Vol. 12, Núm. 10

2016

  1. Fármacos hipolipemiantes y PCSK9

    Clinica e Investigacion en Arteriosclerosis, Vol. 28, pp. 9-13

  2. Impact of late presentation of HIV infection on short-, mid- and long-term mortality and causes of death in a multicenter national cohort: 2004-2013

    Journal of Infection, Vol. 72, Núm. 5, pp. 587-596

  3. MicroRNA profile in CD8+ T-lymphocytes from HIV-infected individuals: Relationship with antiviral immune response and disease progression

    PLoS ONE, Vol. 11, Núm. 5

  4. Short communication: p21/CDKN1A expression shows broad interindividual diversity in a subset of HIV-1 elite controllers

    AIDS Research and Human Retroviruses, Vol. 32, Núm. 3, pp. 232-236

2015

  1. Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study

    PLoS Medicine, Vol. 12, Núm. 3

  2. Entecavir has high efficacy and safety in white patients with chronic hepatitis B and comorbidities

    European Journal of Gastroenterology and Hepatology, Vol. 27, Núm. 1, pp. 46-54

  3. Flavin-containing monooxygenase 3 as a potential player in diabetes-associated atherosclerosis

    Nature Communications, Vol. 6

  4. Normal reference values of left ventricular strain using three-dimensional speckle tracking echocardiography: Results from amulticentre study

    European Heart Journal Cardiovascular Imaging, Vol. 16, Núm. 4, pp. 410-416

  5. Novedades cardiovasculares 2013/2014

    Revista Clinica Espanola, Vol. 215, Núm. 1, pp. 33-42